Recent investigation in mouse models has shown that imidazoquinoline therapy increases the number and activity of Treg cells in part through Treg expression of TLR7; however, opposite findings are reported in cervical cancer patients [40–42]. This evidence concerns the gene TLR7 and cervical carcinoma.